English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51772565    ???header.onlineuser??? :  970
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 506-515 of 883  (89 Page(s) Totally)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:34:15Z Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:14Z ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers Liu W.-H.; Chen C.-H.; Yeh K.-H.; Li C.-L.; Wu Y.-J.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:34:14Z Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel Cheng A.L.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.
臺大學術典藏 2021-07-03T03:34:14Z Reduction of HBV replication prolongs the early immunological response to IFNα therapy Tan A.T.; Hoang L.T.; Chin D.; Rasmussen E.; Lopatin U.; Hart S.; Bitter H.; Chu T.; Gruenbaum L.; Ravindran P.; Zhong H.; Gane E.; Lim S.G.; Chow W.C.; PEI-JER CHEN; Petric R.; Bertoletti A.; Hibberd M.L.
臺大學術典藏 2021-07-03T03:34:14Z Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:13Z SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:34:13Z Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D.
臺大學術典藏 2021-07-03T03:34:12Z Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection Liu C.-J.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:12Z Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏 2021-07-03T03:34:12Z Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality Liu C.-J.; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; PEI-JER CHEN; Lai M.-S.

Showing items 506-515 of 883  (89 Page(s) Totally)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
View [10|25|50] records per page